BridgeBio Pharma (BBIO) Gains from Investment Securities (2018 - 2026)
BridgeBio Pharma recorded quarterly Gains from Investment Securities of $4.1 million in Q1 2026, down 45.17% quarter-over-quarter from $7.4 million in Q4 2025, and up 19300.0% year-over-year from N/an in Q1 2025.
BridgeBio Pharma's Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 19300.0% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $14.6 million (up 733.43% YoY), while the FY2025 annual figure was $14.2 million, up 1302.72% from the prior year.
- Gains from Investment Securities came in at $4.1 million for Q1 2026 at BridgeBio Pharma, down from $7.4 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.4 million in Q4 2025 to a low of -$5.2 million in Q4 2024.
- A 5-year average of $537235.5 and a median of $85374.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities plunged 303.01% in 2024 and soared 19300.0% in 2026, its largest moves.
- BridgeBio Pharma's Gains from Investment Securities stood at -$3.6 million in 2022, then surged by 170.56% to $2.6 million in 2023, then slumped by 303.01% to -$5.2 million in 2024, then soared by 243.24% to $7.4 million in 2025, then slumped by 45.17% to $4.1 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $4.1 million, $7.4 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.07 Mn |
| Mar 31, 2026 | 4.07 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 308,006.00 |
| Jun 30, 2025 | 308,006.00 |
| Mar 31, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | -5.19 Mn |
| Dec 31, 2024 | -5.19 Mn |
| Sep 30, 2024 | 401,924.00 |
| Sep 30, 2024 | 401,924.00 |
| Jun 30, 2024 | 56,159.00 |
| Jun 30, 2024 | 56,159.00 |
| Mar 31, 2024 | 78,915.00 |
| Mar 31, 2024 | 78,915.00 |
| Dec 31, 2023 | 2.56 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 87,584.00 |
| Sep 30, 2023 | 87,584.00 |
| Jun 30, 2023 | 85,374.00 |
| Jun 30, 2023 | 85,374.00 |
| Mar 31, 2023 | 314,000.00 |
| Mar 31, 2023 | 314,000.00 |
| Dec 31, 2022 | -3.62 Mn |
| Dec 31, 2022 | -3.62 Mn |
| Sep 30, 2022 | 53,788.00 |
| Sep 30, 2022 | 53,788.00 |
| Jun 30, 2022 | 54,254.00 |
| Jun 30, 2022 | 54,254.00 |
| Mar 31, 2022 | -604,000.00 |
| Mar 31, 2022 | -604,000.00 |
| Dec 31, 2021 | -11.13 Mn |
| Dec 31, 2021 | -11.13 Mn |
| Sep 30, 2021 | 14,832.00 |
| Sep 30, 2021 | 14,832.00 |
| Jun 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.12 Mn |
| Mar 31, 2021 | -1.23 Mn |
| Mar 31, 2021 | -1.23 Mn |
| Dec 31, 2020 | 6.52 Mn |
| Dec 31, 2020 | 6.52 Mn |
| Sep 30, 2020 | 8,515.00 |
| Sep 30, 2020 | 8,515.00 |
| Jun 30, 2020 | 50,145.00 |
| Jun 30, 2020 | 50,145.00 |
| Mar 31, 2020 | 3,843.00 |
| Mar 31, 2020 | 3,843.00 |
| Dec 31, 2019 | 4.80 Mn |
| Dec 31, 2019 | 4.80 Mn |
| Sep 30, 2019 | 3.73 Mn |
| Sep 30, 2019 | 3.73 Mn |
| Jun 30, 2019 | 537,345.00 |
| Jun 30, 2019 | 537,345.00 |
| Mar 31, 2019 | -339,000.00 |
| Mar 31, 2019 | -339,000.00 |
| Dec 31, 2018 | -245,000.00 |
| Dec 31, 2018 | -245,000.00 |